In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a CARMINE (DISODIUM INDIGO-5,5-DISULFONATE) Drug Master File in Korea (CARMINE (DISODIUM INDIGO-5,5-DISULFONATE) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of CARMINE (DISODIUM INDIGO-5,5-DISULFONATE). The MFDS reviews the CARMINE (DISODIUM INDIGO-5,5-DISULFONATE) KDMF as part of the drug registration process and uses the information provided in the CARMINE (DISODIUM INDIGO-5,5-DISULFONATE) KDMF to evaluate the safety and efficacy of the drug.
After submitting a CARMINE (DISODIUM INDIGO-5,5-DISULFONATE) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their CARMINE (DISODIUM INDIGO-5,5-DISULFONATE) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of CARMINE (DISODIUM INDIGO-5,5-DISULFONATE) suppliers with KDMF on PharmaCompass.